Nectar Lifesciences Board to Consider Q2 Results on 14th Nov'26
Nectar Lifesciences Ltd 路 Intimation 路 14 Nov 2026, 5:30 am
Nectar Lifesciences Board to Consider Q2 Results on 14th Nov'26 Nectar Lifesciences Limited has scheduled a meeting of its Board of Directors on 14th Nov'26. The board will primarily consider, approve, and take on record the company's unaudited financial results for the quarter ended 30th Sep'26, alongside other related business matters, pursuant to SEBI Listing Obligations and Disclosure Requirements Regulations.
Original exchange filing (PDF)
More announcements from Nectar Lifesciences Ltd
- Nectar Lifesciences Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 14 Nov 2026
- Please find attached herewith Results For Quarter And Half Year Ended September 30, 2026. 路 14 Nov 2026
- NECTAR LIFESCIENCES LIMITED has informed the Exchange about Board Meeting to be held on 14-Nov-2026 to consider and approve the Half Yearly Unaudited Financial results of the Company for the period ended September 2026 and Other business. 路 14 Nov 2026
- To consider and approve the financial results for the period ended September 30, 2026 and other business matters 路 14 Nov 2026
- Please find attached herewith copy of minutes of 31st AGM of the Company. 路 05 Oct 2026
- Please find attached herewith disclosures under Regulation 30 of the Securities and Exchange of Board of India (Listing obligations and Disclosure Requirements) Regulations, 2015 路 03 Oct 2026
- Please find attached herewith Revised Proceedings of 31st AGM 路 19 Sept 2026
- Please find attached herewith outcome of Annual General Meeting held on September 18, 2026 with a copy Scrutinizer report and voting results. 路 18 Sept 2026
